Insider Profile · SEC Form 4 Activity · Trailing 90 Days
Wahlstrom Mats
Over the trailing 90 days, Wahlstrom Mats (Director at TriSalus Life Sciences, Inc.) bought $152K of stock across 2 companies, per 6 SEC Form 4 transactions.
- Role
- Director
- Window
- Trailing 90 days · 6 transactions · CIK 1459154
- Net activity
- +$152K ($152K bought · $0 sold)
By Company (Trailing 90 Days)
Transactions (6)
| Date | Symbol | Type | Shares | Value | Description |
|---|---|---|---|---|---|
| 2026-06-05 | CHRS | Buy | 30.0K | $0 | Grant, award or other acquisition |
| 2026-06-05 | CHRS | Buy | 60.0K | $0 | Grant, award or other acquisition |
| 2026-05-15 | TLSI | Buy | 60.0K | $152K | Open market or private purchase |
| 2026-05-14 | TLSI | Buy | 75.2K | $0 | Grant, award or other acquisition |
| 2026-05-14 | TLSI | Buy | 37.6K | $0 | Grant, award or other acquisition |
| 2026-05-14 | TLSI | Buy | 34.2K | $0 | Grant, award or other acquisition |
Activity shown covers the trailing 90 days of SEC Form 4 filings. "Buy" and "sell" follow the SEC acquired/disposed codes and include compensation events (grants, option exercises, tax withholding) unless noted. Historical fact, not investment advice.
Follow Wahlstrom's next move
Real-time Form 4 alerts, insider track records, and cluster detection — matched to your watchlist.